General discussion, page-18246

First 18246 Last

Share
Profile

Follow
Recruiter10

5,140 Posts.

788

14/11/23

15:36

Post #: 70894625
Share

Originally posted by kingkev: ↑

Fair call..........a lot is unknown

What is known is that the ASX is holding us back to an extent and to negate this we have decided to go and play on a much bigger platform (Nasdaq)..........IMO this is just another option we have and one that could surprise to the upside, albeit, it might take many months for that to occur. Conversely it might never work but God loves a trier, and we will try. How will US investors see our products and timelines and hopeful FDA approvals is yet to be understood. Joel and the rest of the executive team would have discussed this at length and completed some extensive dd on this move.

Only guarantees these days is death and taxes but as investors in the BIOTECH sector we come with big dreams, big expectations and big kahunas...........We try and improve humanity by developing products that can serve ever-growing unmet medical needs. Stats are always going to be against us as more fail than succeed but I am only preaching to believers here who want to be part of something spectacular and something that comes with so many risks attached.

Understanding risk here is vital as is patience that will be required but we trend-setters are giving this a red-hot go and may our dreams come true

GLTAH and including the fence-sitters considering jumping on this biotech train while there are still cheap seats available

Expand

Hi mate
can I ask you a question

How is the ASX holding IHL back ?
They are totally impartial.

You may feel IHL has been somehow treated badly by the ASX, but I could counter that & say about other life sciences firms such as Arovella, Avita, Botanix - have all performed very well.

This is down to Funds selling, no funds buying, retail buying only, major shareholder selling etc....
There is nothing that says the ASX has not done anything wrong by IHL.

IHL Price at posting: 5.5¢ Sentiment: Hold Disclosure: Held
10 Upvote

7 Great analysis

Reply

Top Stories

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

What's causing the cost-of-living crisis, and how to navigate it

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t